Cycle on Wheels: Is APP Key to the AppBp1 Pathway?

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Alzheimer's disease (AD) is characterized by progressive cognitive decline and neuronal death.
• Current therapeutic strategies for AD are limited, lacking options to slow, reverse, or prevent disease progression.
• The physiological role of Amyloid Precursor Protein (APP) in AD pathogenesis remains incompletely understood.

Purpose of the Study:

• To analyze existing literature and hypothesize a novel function for APP in Alzheimer's disease.
• To propose that APP's activation of the AppBp1 (neddylation) pathway is diminished during AD progression.
• To explore the potential of this mechanism-driven hypothesis for developing new AD treatment and prevention strategies.

Main Methods:

• Literature review and data analysis.
• Hypothesis formulation based on existing scientific evidence.
• Discussion of molecular mechanisms involving APP, AppBp1 pathway, neddylation, and Cullin ubiquitin ligases.

Main Results:

• Hypothesized that APP physiologically activates the AppBp1 pathway, which is impaired in AD.
• Proposed that the AppBp1 pathway, via neddylation, regulates cell cycle proteins and maintains genome integrity.
• Identified a potential loss of APP-mediated AppBp1 pathway activation during AD pathogenesis.

Conclusions:

• The study presents a novel hypothesis linking APP function to the AppBp1 pathway in AD.
• Dysregulation of the APP-AppBp1 axis may contribute to neuronal dysfunction and genome instability in Alzheimer's disease.
• Further investigation into this pathway could reveal new therapeutic targets for Alzheimer's disease treatment and prevention.